ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994

In Brief: Harkin Proposes To Add Another $400 Million To NCU Budget, Money To Come Forom Defense

July 26, 1991

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014